Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Predictive And Prognostic Value Of CT Based Radiomics Signature In Locally Advanced Head And Neck Cancers Patients Treated With Concurrent Chemoradiotherapy Or Bioradiotherapy And Its Added Value To Human Papillomavirus Status.

Dan Ou, P. Blanchard, S. Rosellini, A. Levy, F. Nguyen, R. Leijenaar, I. Garberis, P. Gorphe, F. Bidault, C. Ferté, C. Robert, O. Casiraghi, J. Scoazec, P. Lambin, S. Témam, E. Deutsch, Y. Tao
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVES To explore prognostic and predictive value of radiomics in patients with locally advanced head and neck squamous cell carcinomas (LAHNSCC) treated with concurrent chemoradiotherapy (CRT) or bioradiotherapy (BRT). MATERIALS AND METHODS Data of 120 patients (CRT vs. BRT matched 2:1) were retrospectively analyzed. A total of 544 radiomics features of the primary tumor were extracted from radiotherapy planning computed tomography scans. Cox proportional hazards models were used to examine the association between survival and radiomics features with false discovery rate correction. The discriminatory performance was evaluated using receiver operating characteristic curve analysis. RESULTS Multivariate analysis showed a 24-feature based signature significantly predicted for OS (HR=0.3, P=0.02) and progression-free survival (PFS) (HR=0.3, P=0.01). Combining the radiomics signature with p16 status showed a significant improvement of prognostic performance compared with p16 (AUC=0.78vs. AUC=0.64 at 5years, P=0.01) or radiomics signature (AUC=0.78vs. AUC=0.67, P=0.01) alone. When patients were stratified according to this combination, OS and PFS were significantly different according to the 4 sub-types (p16+ with low/high signature score; p16- with low/high signature score) (P<0.001). Patients with high signature score significantly benefited from CRT (vs. BRT) in terms of OS (P=0.004), while no benefit from CRT in patients with low signature score. CONCLUSION Our analysis suggests an added value of radiomics features as prognostic and predictive biomarker in HNSCC treated with CRT/BRT. Moreover, the radiomics signature provided additional information to HPV/p16 status to further stratify patients. External validation of such findings is mandatory given the risk of overfitting.
This paper references
10.3109/0284186X.2015.1061214
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma
R. Leijenaar (2015)
10.1016/j.radonc.2014.09.005
Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
E. Rios Velazquez (2014)
10.1016/j.radonc.2015.06.013
Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells.
K. M. Panth (2015)
10.1097/RLI.0000000000000222
Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients
M. Pickles (2016)
10.1007/s00066-014-0626-0
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas
A. Levy (2014)
10.1016/j.radonc.2015.02.015
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
T. Coroller (2015)
10.3174/ajnr.A4285
Using Texture Analysis to Determine Human Papillomavirus Status of Oropharyngeal Squamous Cell Carcinomas on CT
K. Buch (2015)
10.1148/radiol.13130110
Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy.
Hao-wei Zhang (2013)
10.1200/JCO.2012.46.7746
Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?
H. Quon (2013)
10.1038/srep11044
Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
Chintan Parmar (2015)
10.1158/0008-5472.CAN-12-2606
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
C. Badoual (2013)
10.1016/j.ejca.2011.11.036
Radiomics: extracting more information from medical images using advanced feature analysis.
P. Lambin (2012)
10.1038/bjc.2015.139
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe
M. M. Rietbergen (2015)
10.1200/JCO.2015.64.7586
Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Z. Husain (2016)
10.1016/j.crad.2011.08.012
Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival.
B. Ganeshan (2012)
10.1097/RCT.0000000000000320
Difference Between HPV-Positive and HPV-Negative Non-Oropharyngeal Head and Neck Cancer: Texture Analysis Features on CT
A. Fujita (2016)
10.1016/j.radonc.2009.04.014
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
J. Pignon (2009)
10.1016/J.YPED.2010.12.093
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
J. Stockman (2012)
10.1038/ncomms5006
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
10.1200/JCO.2015.61.2358
Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.
A. Bhatia (2015)
10.1016/j.radonc.2010.04.022
The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
P. Lassen (2010)
10.1148/radiol.12120254
Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.
F. Ng (2013)
10.1016/j.oraloncology.2016.05.019
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
Dan Ou (2016)
10.1148/radiol.13122869
Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy.
C. Yip (2014)



This paper is referenced by
10.23736/S1824-4785.19.03192-3
CT radiomics and PET radiomics: ready for clinical implementation?
M. Bogowicz (2019)
10.1016/j.radonc.2019.05.019
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
J. M. Moan (2019)
QUANTITATIVE IMAGING FOR PRECISION MEDICINE IN HEAD AND NECK CANCER PATIENTS
R. Ger (2019)
10.1016/j.crad.2020.08.030
Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
J. Zhong (2020)
10.1055/s-0043-121964
Radiomics: Big Data Instead of Biopsies in the Future?
K. Scheckenbach (2018)
10.3748/wjg.v26.i24.3458
Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy
S. L. Polk (2020)
10.1259/bjr.20170926
A review on radiomics and the future of theranostics for patient selection in precision medicine.
Simon A Keek (2018)
10.1007/s00066-019-01483-0
Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics
L. Cozzi (2019)
10.1016/j.ejmp.2019.03.024
Early survival prediction in non-small cell lung cancer from PET/CT images using an intra-tumor partitioning method.
M. Astaraki (2019)
10.1016/S1470-2045(19)30177-9
Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review.
V. Budach (2019)
Application of radiomics and machine learning in head and neck cancers
Zhouying Peng (2020)
10.1016/j.canrad.2020.01.011
Radiomics: A primer for the radiation oncologist.
J. Bibault (2020)
10.1177/0846537120942134
Utilizing Artificial Intelligence for Head and Neck Cancer Outcomes Prediction From Imaging.
Tricia Chinnery (2020)
10.3389/fonc.2019.01118
Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16– High Risk Head and Neck Cancer
Yue Cao (2019)
10.3389/fonc.2020.575422
A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer
Yanpeng Chu (2020)
10.1055/S-0043-121596
HPV – Das andere Kopf-Hals-Karzinom
C. Wittekindt (2018)
10.3389/fonc.2019.00821
CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades
Wenli Wu (2019)
10.1148/rycan.2020190039
CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
P. Mukherjee (2020)
10.3390/cancers13010057
Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers
P. Giraud (2020)
10.3389/fonc.2019.00174
Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
P. Giraud (2019)
10.3389/fonc.2019.00383
Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
M. Taberna (2019)
10.1186/s13014-019-1339-4
Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands
K. Sheikh (2019)
10.1117/12.2512789
Using imaging biomarkers to predict radiation induced xerostomia in head and neck cancer
K. Sheikh (2019)
10.1016/j.compmedimag.2018.09.002
Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis
R. Ger (2018)
10.25670/OI2019-010ON
Možnosti deintenzifikacije zdravljenja HPV pozitivnih ploščatoceličnih karcinomov orofarinksa
G. Plavc (2019)
10.1016/j.oraloncology.2020.104625
Dosiomics improves prediction of locoregional recurrence for intensity modulated radiotherapy treated head and neck cancer cases.
Aiqian Wu (2020)
10.1038/s41598-018-31509-z
Comprehensive Investigation on Controlling for CT Imaging Variabilities in Radiomics Studies
R. Ger (2018)
10.3390/cancers11101409
Radiomics and Texture Analysis in Laryngeal Cancer. Looking for New Frontiers in Precision Medicine through Imaging Analysis
C. Chiesa-Estomba (2019)
10.1259/bjr.20190948
Radiomics: from qualitative to quantitative imaging.
W. Rogers (2020)
10.1007/s11307-018-01304-3
Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma
Wenbing Lv (2019)
10.2147/IJN.S233294
Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
Chuanhui Song (2020)
10.1007/s00066-020-01638-4
Radiomic biomarkers for head and neck squamous cell carcinoma
S. Tanadini-Lang (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar